P3-GemOx as a novel immunochemotherapy candidate in NK/T-cell lymphoma management
Authors
- Zhipeng Cheng (ORCID: https://orcid.org/0000-0002-4507-9037)
- Yuyang Zhang (ORCID: https://orcid.org/0000-0002-3806-6094)
- Liang Tang (ORCID: https://orcid.org/0000-0002-3253-0220)
- Xin Lü (ORCID: https://orcid.org/0000-0002-6587-1152)
- Yu Hu
- Haiming Kou
Institutions
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-23
- DOI
- https://doi.org/10.3389/fmed.2025.1666601
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China